Clinical impact of HLA class I expression in rectal cancer Frank M. SpeetjensElza C. de BruinPeter J. K. Kuppen Original Article Open access 15 September 2007 Pages: 601 - 609
An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2 Tsukasa NabekuraToshiro NagasawaMasafumi Onodera Original Article 05 September 2007 Pages: 611 - 622
Adoptive transfer of Treg depleted autologous T cells in advanced renal cell carcinoma Fiona C. ThistlethwaiteEyad ElkordRobert E. Hawkins Original Article 27 September 2007 Pages: 623 - 634
Migration deficit in monocyte-macrophages in human ovarian cancer Ralph S. FreedmanQing MaFrancesco M. Marincola Original Article 10 October 2007 Pages: 635 - 645
Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells A. Nazmul H. KhanChristopher J. GregorieThomas B. Tomasi Original Article 28 November 2007 Pages: 647 - 654
Ly49G2 receptor blockade reduces tumor burden in a leukemia model but not in a solid tumor model Melissa A. BarberTong ZhangCharles L. Sentman Original Article 22 September 2007 Pages: 655 - 662
Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transduction Hovav NechushtanDien PhamJoseph D. Rosenblatt Original Article 19 October 2007 Pages: 663 - 675
Immunogenicity of Iodine 131 chimeric tumor necrosis therapy monoclonal antibody in advanced lung cancer patients Hui WangChuanping CaoDianwen Ju Original Article 13 October 2007 Pages: 677 - 684
Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy Selma UgurelDavid SchramaJürgen C. Becker Original Article 02 October 2007 Pages: 685 - 691
MYCN as a target for cancer immunotherapy Nourredine HimoudiMengyong YanJohn Anderson Original Article 15 November 2007 Pages: 693 - 700
Anti-inflammatory pretreatment enables an efficient dendritic cell-based immunotherapy against established tumors Paula ChiarellaMarisa VulcanoRaúl A. Ruggiero Original Article 26 October 2007 Pages: 701 - 718
Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines Rosa MéndezTeresa RodríguezFederico Garrido Original Article 13 October 2007 Pages: 719 - 729
Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma Anna De GeerLena-Maria CarlsonJelena Levitskaya Original Article 26 October 2007 Pages: 731 - 743
A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes Pierre LarrieuVirginie RenaudJean-François Fonteneau Original Article 21 December 2007 Pages: 745 - 752